Notice: This company has been marked as potentially delisted and may not be actively trading. Humanigen (HGEN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Former Humanigen director arrested for insider tradingDecember 25, 2024 | msn.comUS says former Humanigen chief scientific officer charged with insider tradingDecember 23, 2024 | reuters.comHumanigen, Inc. (HGEN)October 10, 2024 | finance.yahoo.com0KB1.SG,0P00011RKD,0 (0KB1.SG)August 4, 2024 | ca.finance.yahoo.comHumanigen Inc (0KB2.BE)March 24, 2024 | finance.yahoo.comHumanigen Inc HGENQFebruary 6, 2024 | morningstar.comLevi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action SettlementJanuary 25, 2024 | markets.businessinsider.comFirm Retention Summary: HumanigenJanuary 17, 2024 | wsj.comHumanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, BankruptcyJanuary 5, 2024 | msn.comCOVID-19 treatment developer Humanigen files for Chapter 11 bankruptcyJanuary 4, 2024 | news.yahoo.comCovid-19 Treatment Developer Humanigen Files for BankruptcyJanuary 4, 2024 | wsj.comCOVID pick Humanigen files for bankruptcyJanuary 4, 2024 | msn.comAktueller Chart HUMANIGEN AktieDecember 9, 2023 | finanznachrichten.deHumanigen, Inc. (HGEN) stock historical prices & data – Yahoo FinanceOctober 13, 2023 | uk.finance.yahoo.comHumanigen, Inc. (HGEN) stock price, news, quote & history – Yahoo FinanceAugust 11, 2023 | uk.finance.yahoo.comHumanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell TransplantationAugust 7, 2023 | finance.yahoo.comHumanigen stock removed from S&P Total Market Index as firm faces...July 30, 2023 | proactiveinvestors.comHumanigen stock removed from S&P Total Market Index as firm faces bankruptcyJuly 28, 2023 | proactiveinvestors.comHumanigen Shares Plunge 73% as Business Combination Fails, Going Concern Issues RaisedJuly 25, 2023 | marketwatch.comWhy Is Humanigen (HGEN) Stock Down 72% Today?July 25, 2023 | markets.businessinsider.comHumanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming LargeJuly 25, 2023 | msn.comHumanigen to weigh bankruptcy as shares delist from NasdaqJuly 25, 2023 | seekingalpha.comHumanigen (HGEN) Surges on Lenzilumab Study Data for LeukemiaApril 17, 2023 | nasdaq.comHumanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of LeukemiaApril 14, 2023 | finance.yahoo.comHumanigen, Inc. (HGEN) Stock Historical Prices & Data - Yahoo FinanceDecember 20, 2022 | finance.yahoo.comHumanigen Reports Third Quarter 2022 Financial ResultsNovember 14, 2022 | finance.yahoo.comHumanigen Announces Participation and Presentation at Jefferies London Healthcare ConferenceNovember 10, 2022 | finance.yahoo.comHumanigen Announces Retention of SC&H Capital as Financial AdvisorOctober 31, 2022 | finance.yahoo.com2022-10-19 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 19, 2022 | stockhouse.comThis Addiction Drug Shows Some Potential Against Long COVID Symptoms - Humanigen (NASDAQ:HGEN), GSK (NYSE - BenzingaOctober 19, 2022 | benzinga.comCLASS ACTION UPDATE for HGEN, SQ and OPEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Be - BenzingaOctober 19, 2022 | benzinga.comGLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – HGEN - Business WireOctober 18, 2022 | businesswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGENOctober 18, 2022 | prnewswire.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm - GuruFocus.comOctober 17, 2022 | gurufocus.comHGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upc - BenzingaOctober 16, 2022 | benzinga.com2022-10-15 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 15, 2022 | stockhouse.comHGEN SHAREHOLDER ALERT: Jakubo - GuruFocus.comOctober 14, 2022 | gurufocus.com2022-10-14 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 14, 2022 | stockhouse.comHGEN LAWSUIT ALERT: Levi & Kor - GuruFocus.comOctober 13, 2022 | gurufocus.comROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Bef - BenzingaOctober 13, 2022 | benzinga.com2022-10-13 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 13, 2022 | stockhouse.comHumanigen Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2022 - BenzingaOctober 12, 2022 | benzinga.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, - BenzingaOctober 11, 2022 | benzinga.com2022-10-09 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 10, 2022 | stockhouse.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important De - BenzingaOctober 10, 2022 | benzinga.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN - PR NewswireOctober 8, 2022 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGENOctober 8, 2022 | prnewswire.comHGEN.N - Humanigen Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.com2022-10-06 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 7, 2022 | stockhouse.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch F - BenzingaOctober 6, 2022 | benzinga.com Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address HGEN Media Mentions By Week HGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HGEN News Sentiment▼0.000.64▲Average Medical News Sentiment HGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HGEN Articles This Week▼00▲HGEN Articles Average Week Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News Apollomics News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Lexaria Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HGEN) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humanigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humanigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
